Lexicon Pharmaceuticals (LXRX) Non Operating Interest Expenses (2010 - 2026)
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Lexicon Pharmaceuticals | 978.15 Mn | 787.54 Mn | 653,000.00 | 2.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.61 Mn |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 3.86 Mn |
| Sep 30, 2024 | 4.56 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 4.95 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 3.90 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 864,000.00 |
| Jun 30, 2022 | 703,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 171,000.00 |